Cargando…

Methods for the Drug Effectiveness Review Project

The Drug Effectiveness Review Project was initiated in 2003 in response to dramatic increases in the cost of pharmaceuticals, which lessened the purchasing power of state Medicaid budgets. A collaborative group of state Medicaid agencies and other organizations formed to commission high-quality comp...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonagh, Marian S, Jonas, Daniel E, Gartlehner, Gerald, Little, Alison, Peterson, Kim, Carson, Susan, Gibson, Mark, Helfand, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532217/
https://www.ncbi.nlm.nih.gov/pubmed/22970848
http://dx.doi.org/10.1186/1471-2288-12-140
_version_ 1782254275240394752
author McDonagh, Marian S
Jonas, Daniel E
Gartlehner, Gerald
Little, Alison
Peterson, Kim
Carson, Susan
Gibson, Mark
Helfand, Mark
author_facet McDonagh, Marian S
Jonas, Daniel E
Gartlehner, Gerald
Little, Alison
Peterson, Kim
Carson, Susan
Gibson, Mark
Helfand, Mark
author_sort McDonagh, Marian S
collection PubMed
description The Drug Effectiveness Review Project was initiated in 2003 in response to dramatic increases in the cost of pharmaceuticals, which lessened the purchasing power of state Medicaid budgets. A collaborative group of state Medicaid agencies and other organizations formed to commission high-quality comparative effectiveness reviews to inform evidence-based decisions about drugs that would be available to Medicaid recipients. The Project is coordinated by the Center for Evidence-based Policy (CEbP) at Oregon Health & Science University (OHSU), and the systematic reviews are undertaken by the Evidence-based Practice Centers (EPCs) at OHSU and at the University of North Carolina. The reviews adhere to high standards for comparative effectiveness reviews. Because the investigators have direct, regular communication with policy-makers, the reports have direct impact on policy and decision-making, unlike many systematic reviews. The Project was an innovator of methods to involve stakeholders and continues to develop its methods in conducting reviews that are highly relevant to policy-makers. The methods used for selecting topics, developing key questions, searching, determining eligibility of studies, assessing study quality, conducting qualitative and quantitative syntheses, rating the strength of evidence, and summarizing findings are described. In addition, our on-going interactions with the policy-makers that use the reports are described.
format Online
Article
Text
id pubmed-3532217
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35322172013-01-03 Methods for the Drug Effectiveness Review Project McDonagh, Marian S Jonas, Daniel E Gartlehner, Gerald Little, Alison Peterson, Kim Carson, Susan Gibson, Mark Helfand, Mark BMC Med Res Methodol Correspondence The Drug Effectiveness Review Project was initiated in 2003 in response to dramatic increases in the cost of pharmaceuticals, which lessened the purchasing power of state Medicaid budgets. A collaborative group of state Medicaid agencies and other organizations formed to commission high-quality comparative effectiveness reviews to inform evidence-based decisions about drugs that would be available to Medicaid recipients. The Project is coordinated by the Center for Evidence-based Policy (CEbP) at Oregon Health & Science University (OHSU), and the systematic reviews are undertaken by the Evidence-based Practice Centers (EPCs) at OHSU and at the University of North Carolina. The reviews adhere to high standards for comparative effectiveness reviews. Because the investigators have direct, regular communication with policy-makers, the reports have direct impact on policy and decision-making, unlike many systematic reviews. The Project was an innovator of methods to involve stakeholders and continues to develop its methods in conducting reviews that are highly relevant to policy-makers. The methods used for selecting topics, developing key questions, searching, determining eligibility of studies, assessing study quality, conducting qualitative and quantitative syntheses, rating the strength of evidence, and summarizing findings are described. In addition, our on-going interactions with the policy-makers that use the reports are described. BioMed Central 2012-09-12 /pmc/articles/PMC3532217/ /pubmed/22970848 http://dx.doi.org/10.1186/1471-2288-12-140 Text en Copyright ©2012 McDonagh et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
McDonagh, Marian S
Jonas, Daniel E
Gartlehner, Gerald
Little, Alison
Peterson, Kim
Carson, Susan
Gibson, Mark
Helfand, Mark
Methods for the Drug Effectiveness Review Project
title Methods for the Drug Effectiveness Review Project
title_full Methods for the Drug Effectiveness Review Project
title_fullStr Methods for the Drug Effectiveness Review Project
title_full_unstemmed Methods for the Drug Effectiveness Review Project
title_short Methods for the Drug Effectiveness Review Project
title_sort methods for the drug effectiveness review project
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532217/
https://www.ncbi.nlm.nih.gov/pubmed/22970848
http://dx.doi.org/10.1186/1471-2288-12-140
work_keys_str_mv AT mcdonaghmarians methodsforthedrugeffectivenessreviewproject
AT jonasdaniele methodsforthedrugeffectivenessreviewproject
AT gartlehnergerald methodsforthedrugeffectivenessreviewproject
AT littlealison methodsforthedrugeffectivenessreviewproject
AT petersonkim methodsforthedrugeffectivenessreviewproject
AT carsonsusan methodsforthedrugeffectivenessreviewproject
AT gibsonmark methodsforthedrugeffectivenessreviewproject
AT helfandmark methodsforthedrugeffectivenessreviewproject